Featured Stories
Utah Attorney General Office Urges Consumers to Claim Compensation for Inflated Generic Drug Prices
SALT LAKE CITY, Utah, Oct. 9 -- The Utah Attorney General Office issued the following news:
* * *
Utah urges consumers to claim compensation for inflated generic drug prices
Court gives preliminary approval to plan returning settlement money to consumers who overpaid for generic drugs
-
Salt Lake City, Utah--Utahns who paid for certain generic drugs between May 2009 and December 2019 may be eligible for compensation. On September 8, the U.S. District Court for the District of Connecticut gave preliminary approval to a plan to distribute approximately $96.5 million in settlement funds.
Utah
... Show Full Article
SALT LAKE CITY, Utah, Oct. 9 -- The Utah Attorney General Office issued the following news:
* * *
Utah urges consumers to claim compensation for inflated generic drug prices
Court gives preliminary approval to plan returning settlement money to consumers who overpaid for generic drugs
-
Salt Lake City, Utah--Utahns who paid for certain generic drugs between May 2009 and December 2019 may be eligible for compensation. On September 8, the U.S. District Court for the District of Connecticut gave preliminary approval to a plan to distribute approximately $96.5 million in settlement funds.
Utahand 47 other states and territories reached those settlements with generic drug manufacturers Glenmark, Lannett, Bausch, Apotex, Heritage, and Heritage's parent company, Emcure.
The states allege these companies illegally conspired to inflate the prices of generic drugs by violating antitrust and consumer protection laws. The settling companies have not admitted wrongdoing.
How to file a claim
If you purchased a generic drug on the settlement drug list between May 2009 and December 2019, you may be eligible for compensation. To check eligibility or file a claim, call 1-866-290-0182 (Toll-Free), email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com. The claim deadline is March 8, 2027.
Litigation background
Utah belongs to a coalition of nearly every state and territory pursuing a series of antitrust cases against the generic drug industry. The investigation began in 2016 and has produced four complaints:
* The first complaint, filed in 2016, names Heritage, 17 other companies and two individual executives over 15 generic drugs.
*
The second complaint, filed in 2019, targets Teva Pharmaceuticals and 21 other major generic manufacturers, along with 16 senior executives.
* The third complaint covers 80 topical generic drugs worth billions of dollars in U.S. sales. It names 26 companies and 10 individuals and will be the first case tried.
* The fourth complaint alleges that Novartis AG, Sandoz Group AG and Sandoz AG are liable for Sandoz's alleged conduct and for fraudulently transferring assets.
The states built these cases on testimony from cooperating witnesses, millions of documents, and an extensive phone record database. Seven pharmaceutical executives are cooperating with the states. The complaints allege that competing executives met and communicated regularly, giving them opportunities to reach illegal agreements. According to the complaints, defendants used phrases like "fair share," "playing nice in the sandbox" and "responsible competitor" to discourage competition, raise prices and enforce a culture of collusion.
Utah was joined in the announcement by Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming joined in the announcement.
* * *
Original text here: https://attorneygeneral.utah.gov/utah-consumers-claim-compensation-inflated-generic-drugs/
Okla. A.G. Drummond Asks DEQ to Revise Proposed Rules, Continues Fight Against Inola Aluminum Smelter
OKLAHOMA CITY, Oklahoma, Oct. 9 -- Oklahoma Attorney General Gentner Drummond issued the following news release:
* * *
Drummond asks DEQ to revise proposed rules, continues fight against Inola aluminum smelter
OKLAHOMA CITY (Oct. 8, 2026) - Attorney General Gentner Drummond has asked the Oklahoma Department of Environmental Quality (DEQ) to ensure that a proposed air quality rule cannot be used to permit the aluminum smelter planned for Inola if the project fails to meet federal ozone limits on its own.
The proposal would allow a major new source that cannot show it will keep ozone within federal
... Show Full Article
OKLAHOMA CITY, Oklahoma, Oct. 9 -- Oklahoma Attorney General Gentner Drummond issued the following news release:
* * *
Drummond asks DEQ to revise proposed rules, continues fight against Inola aluminum smelter
OKLAHOMA CITY (Oct. 8, 2026) - Attorney General Gentner Drummond has asked the Oklahoma Department of Environmental Quality (DEQ) to ensure that a proposed air quality rule cannot be used to permit the aluminum smelter planned for Inola if the project fails to meet federal ozone limits on its own.
The proposal would allow a major new source that cannot show it will keep ozone within federallimits to obtain a permit by purchasing emission credits from another facility. In a letter to the agency today, Drummond asked DEQ to revise its proposed rules and to bar the use of the proposed new offset option for any permit application filed before the rules take effect. The air permit application for the proposed Inola smelter was filed in February and amended in September. According to that application, a preliminary estimate places the project's ozone impact within four percent of the federal significance threshold.
Drummond noted several concerns about the proposed rules, including that they count credits by the ton without requiring proof that they protect air quality where the project's impact occurs. He added that the rules fail to account for geographic and seasonal factors and that several of the provisions contradict one another.
"An offset program is consistent with the Prevention of Significant Deterioration program only if it holds each applicant to the showing that federal law and DEQ's own rules already require, which is that the air where people live will be no worse for the project," Drummond said in the letter.
Drummond initially filed a petition in June to stop development of Oklahoma Primary Aluminum, a massive proposed smelter near Inola. His lawsuit seeks to protect the health of area residents, livestock and natural resources from the threatened public nuisance posed by the project. Drummond also has a pending motion for preliminary injunction seeking to block construction of the proposed smelter while the lawsuit is decided.
Read the Letter (https://oklahoma.gov/content/dam/ok/en/oag/news-documents/2026/october/Letter_DEQ_Foster_Amendment%2010.08.2026.pdf)
* * *
Original text here: https://oklahoma.gov/oag/news/newsroom/2026/october/drummond-asks-deq-to-revise-proposed-rules-continues-fight-against-inola-aluminum-smelter.html
N.H. A.G. Formella: Officer-Involved Shooting Investigation in Bath, New Hampshire
CONCORD, New Hampshire, Oct. 9 -- New Hampshire Attorney General John Formella issued the following news release:
* * *
October 08, 2026
Officer-Involved Shooting Investigation in Bath, New Hampshire
Concord, NH - Attorney General John M. Formella announces that members of the New Hampshire Attorney General's Office and the New Hampshire State Police Major Crime Unit are responding to a report of an officer-involved shooting that occurred Thursday evening in Bath, New Hampshire.
According to initial police reports provided to investigators, State Troopers and local police had been pursuing
... Show Full Article
CONCORD, New Hampshire, Oct. 9 -- New Hampshire Attorney General John Formella issued the following news release:
* * *
October 08, 2026
Officer-Involved Shooting Investigation in Bath, New Hampshire
Concord, NH - Attorney General John M. Formella announces that members of the New Hampshire Attorney General's Office and the New Hampshire State Police Major Crime Unit are responding to a report of an officer-involved shooting that occurred Thursday evening in Bath, New Hampshire.
According to initial police reports provided to investigators, State Troopers and local police had been pursuinga vehicle they had been trying to locate earlier in the day. Law enforcement report that the vehicle stopped near the intersections of Route 302 and Route 112, where Troopers and an officer made contact with an adult female. Police say the female was armed with what appeared to be a handgun. During the interaction, gunshots were fired, and the female was injured. She was transported to an area hospital where she has since been pronounced deceased.
There is no known threat to the public at this time, and no other private citizens or law enforcement suffered physical injuries. The exact circumstances surrounding this incident are now under active investigation. More information will be released as it becomes available.
* * *
Original text here: https://www.doj.nh.gov/news-and-media/officer-involved-shooting-investigation-bath-new-hampshire
N.H. A.G. Formella: Determination Made on Use of Force in Officer-Involved Shooting in Milan, New Hampshire on May 21, 2026
CONCORD, New Hampshire, Oct. 9 -- New Hampshire Attorney General John Formella issued the following news release:
* * *
October 08, 2026
Determination Made on Use of Force in Officer-Involved Shooting in Milan, New Hampshire on May 21, 2026
Concord, NH - Attorney General John M. Formella announces that the Attorney General's Office has made a determination as to the lawfulness of the police officer shooting of Zachary Gagne (age 38) in Milan, New Hampshire on the evening of May 21, 2026.
At about 8:54 p.m. on May 21, Corporal Jason Silva of the Berlin Police Department responded to a 911 call
... Show Full Article
CONCORD, New Hampshire, Oct. 9 -- New Hampshire Attorney General John Formella issued the following news release:
* * *
October 08, 2026
Determination Made on Use of Force in Officer-Involved Shooting in Milan, New Hampshire on May 21, 2026
Concord, NH - Attorney General John M. Formella announces that the Attorney General's Office has made a determination as to the lawfulness of the police officer shooting of Zachary Gagne (age 38) in Milan, New Hampshire on the evening of May 21, 2026.
At about 8:54 p.m. on May 21, Corporal Jason Silva of the Berlin Police Department responded to a 911 callwhere Mr. Gagne's wife requested police assistance. During that incident, Corporal Silva fired several shots at Zachary Gagne, striking him in the hand, upper arm, and abdomen.
Although Mr. Gagne survived, Corporal Silva's shooting of him constitutes the use of deadly force under the law. The Attorney General's Office has conducted a full investigation in order to determine whether the use of deadly force against Mr. Gagne was legally justified. After a review of evidence gathered during the course of the investigation, the Attorney General has determined that Corporal Silva's shooting of Zachary Gagne was a legally justified use of deadly force.
The Coos County Attorney's Office has initiated legal proceedings against Zachary Gagne in connection with events relating to his May 21st encounter with Corporal Silva. Those charges are pending. N.H. Rules of Professional Conduct 3.6(a) states that "a lawyer who . . . has participated in the investigation . . . of a matter shall not make an extrajudicial statement that the lawyer knows or reasonably should know will be disseminated by means of public communication and will have a substantial likelihood of materially prejudicing an adjudicative proceeding in the matter." As a result, the Attorney General's Office is unable to release further information about its investigation at this time. However, when the current legal proceedings against Mr. Gagne have concluded, the Attorney General's Office will issue its full report on the investigation into Corporal Silva's use of deadly force, with the associated findings and reasoning behind the determination made.
* * *
Original text here: https://www.doj.nh.gov/news-and-media/determination-made-use-force-officer-involved-shooting-milan-new-hampshire-may-21
Maine A.G. Frey Seeks Court Approval for Settlements With Ascend, Citron, Mayne Pharma Over Conspiracy to Inflate Prices, Limit Competition
AUGUSTA, Maine, Oct. 9 -- Maine Attorney General Aaron Frey issued the following news release:
* * *
Attorney General Aaron M. Frey Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Pharma Over Conspiracy to Inflate Prices and Limit Competition
10/08/2026
If You Bought Certain Generic Prescription Drugs in the United States Between May 2009 and December 2019, You Could be Eligible for Money
-
AUGUSTA - Attorney General Aaron M. Frey today joined a coalition of 45 states and territories seeking court approval of three settlements with Ascend Laboratories, Citron Pharma and
... Show Full Article
AUGUSTA, Maine, Oct. 9 -- Maine Attorney General Aaron Frey issued the following news release:
* * *
Attorney General Aaron M. Frey Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Pharma Over Conspiracy to Inflate Prices and Limit Competition
10/08/2026
If You Bought Certain Generic Prescription Drugs in the United States Between May 2009 and December 2019, You Could be Eligible for Money
-
AUGUSTA - Attorney General Aaron M. Frey today joined a coalition of 45 states and territories seeking court approval of three settlements with Ascend Laboratories, Citron Pharma andMayne Pharma to resolve allegations that the generic drug manufacturers engaged in a widespread, long-running conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs.
Ascend will pay $400,000 to the states. Mayne will pay $650,000. Citron's settlement only includes non-monetary terms as it has ceased business operations. As part of the settlement, the companies each agreed to meaningful injunctive terms including a series of internal reforms to ensure fair competition and compliance with antitrust laws.
These latest settlements come as the States prepare for the first trial to be held in Hartford, Connecticut in February 2027.
The States previously reached settlements with Sandoz, Glenmark, Lannett, Bausch, Apotex, Heritage, and Heritage's parent company, Emcure, totaling $496.5 million.
If you purchased a generic prescription drug between May 2009 and December 2019, you may be eligible for compensation. To determine your eligibility, call 1-866-290-0182 (Toll-Free), email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com. You can submit a claim for compensation.
Connecticut is leading a coalition of nearly all states and territories engaged in a series of antitrust cases, starting first in 2016. The first Complaint included Heritage and 17 other corporate Defendants, two individual Defendants, and 15 generic drugs. Two former executives from Heritage Pharmaceuticals, Jeffery Glazer and Jason Malek, have since entered into settlement agreements and are cooperating. The second Complaint was filed in 2019 against Teva Pharmaceuticals and 21 of the nation's largest generic drug manufacturers. The Complaint names 16 individual senior executive Defendants. The third complaint, to be tried first, focuses on 80 topical generic drugs that account for billions of dollars of sales in the United States and names 26 corporate defendants and 10 individual defendants. The States filed a fourth complaint earlier this year, alleging that Novartis AG, Sandoz Group AG and Sandoz AG, are liable for Sandoz's alleged conduct and for fraudulently transferring assets.
The cases all stem from a series of investigations built on evidence from several cooperating witnesses at the core of the different conspiracies, a massive document database of more than 20 million documents, and a phone records database containing millions of call detail records and contact information for more than 600 sales and pricing individuals in the generics industry. Each complaint addresses a different set of drugs and defendants and lays out an interconnected web of competing industry executives that met with each other during industry dinners, "girls' nights out," lunches, cocktail parties, golf outings, and communicated via frequent telephone calls, emails, and text messages that sowed the seeds for their illegal agreements. Throughout the complaints, defendants use terms like "fair share," "playing nice in the sandbox," and "responsible competitor" to describe how they unlawfully discouraged competition, raised prices, and enforced an ingrained culture of collusion. Among the records obtained by the States is a two-volume notebook containing the contemporaneous notes of one of the States' cooperators that memorialized his discussions during phone calls with competitors and internal company meetings over a period of several years.
States and territories also joining the settlements include: Alaska, Arizona, California, Colorado, Connecticut, Delaware, the District of Columbia, Florida, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.
* * *
Original text here: https://www.maine.gov/ag/news-and-library/press-releases/attorney-general-aaron-m-frey-seeks-court-approval-settlements
Attorney General Formella Seeks Court Approval for Generic Drug Price-Fixing Settlements to Benefit New Hampshire Consumers
CONCORD, New Hampshire, Oct. 9 -- New Hampshire Attorney General John Formella issued the following news release:
* * *
October 08, 2026
Attorney General Formella Seeks Court Approval for Generic Drug Price-Fixing Settlements to Benefit New Hampshire Consumers
Concord, NH - Attorney General John M. Formella announces that New Hampshire has joined a coalition of 45 states and territories seeking court approval of three settlements with Ascend Laboratories, Citron Pharma and Mayne Pharma to resolve allegations that the generic drug manufacturers engaged in a widespread, long-running conspiracy
... Show Full Article
CONCORD, New Hampshire, Oct. 9 -- New Hampshire Attorney General John Formella issued the following news release:
* * *
October 08, 2026
Attorney General Formella Seeks Court Approval for Generic Drug Price-Fixing Settlements to Benefit New Hampshire Consumers
Concord, NH - Attorney General John M. Formella announces that New Hampshire has joined a coalition of 45 states and territories seeking court approval of three settlements with Ascend Laboratories, Citron Pharma and Mayne Pharma to resolve allegations that the generic drug manufacturers engaged in a widespread, long-running conspiracyto artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs.
"These settlements hold generic drug manufacturers accountable for conduct that undermines competition and drives up costs for consumers," said Attorney General Formella. "New Hampshire will continue to work with other states to protect competition and ensure that companies follow the rules."
These settlements focus primarily on injunctive relief. As part of the settlement, the companies each agreed to meaningful injunctive terms including a series of internal reforms to ensure fair competition and compliance with antitrust laws. These latest settlements come as the States prepare for the first trial to be held in February 2027. The States previously reached settlements with Sandoz, Glenmark, Lannett, Bausch, Apotex and Heritage, and Heritage's parent company, Emcure, totaling $496.5 million.
If you purchased a generic prescription drug between May 2009 and December 2019, you may be eligible for compensation. To determine your eligibility, call 1-866-290-0182 (Toll-Free), email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com. You can submit a claim for compensation here.
New Hampshire is part of a coalition of nearly all states and territories pursuing a series of antitrust cases against generic drug manufacturers. The investigations began in 2016 with a complaint against Heritage Pharmaceuticals and other defendants involving 15 generic drugs. Two former Heritage executives, Jeffery Glazer and Jason Malek, have since entered into settlement agreements and are cooperating with the states.
A second complaint, filed in 2019, names Teva Pharmaceuticals and 21 other major generic drug manufacturers, as well as 16 senior executives. A third complaint, which is scheduled to be tried first, focuses on 80 topical generic drugs representing billions of dollars in U.S. sales and names 26 corporate and 10 individual defendants. Earlier this year, the states filed a fourth complaint against Novartis AG, Sandoz Group AG and Sandoz AG, alleging liability for Sandoz's conduct and fraudulent transfers of assets.
The cases are based on evidence from cooperating witnesses, more than 20 million documents and millions of telephone records involving more than 600 sales and pricing executives in the generic drug industry. The complaints allege that competing executives communicated by phone, email and text and met at industry gatherings to coordinate pricing and limit competition. The evidence also includes contemporaneous notes from a cooperating witness documenting conversations with competitors and internal company meetings over several years.
In addition to New Hampshire, states and territories joining the settlements include: Alaska, Arizona, California, Colorado, Connecticut, Delaware, the District of Columbia, Florida, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.
The New Hampshire Department of Justice Consumer Protection and Antitrust Bureau investigates unfair, deceptive, or unreasonable practices involving New Hampshire consumers. To file a complaint with the New Hampshire Department of Justice, visit https://www.doj.nh.gov/consumer/complaints.
* * *
Original text here: https://www.doj.nh.gov/news-and-media/attorney-general-formella-seeks-court-approval-generic-drug-price-fixing-settlements
Ariz. A.G. Mayes Sues TikTok for Harming Arizona Youth
PHOENIX, Arizona, Oct. 9 -- Arizona Attorney General Kris Mayes issued the following news release:
* * *
Attorney General Mayes Sues TikTok for Harming Arizona Youth
October 8, 2026
PHOENIX - Attorney General Kris Mayes today announced the filing of a consumer protection lawsuit against TikTok Inc. and related entities. The complaint alleges widespread violations of the Arizona Consumer Fraud Act stemming from the company's design, marketing, and concealment of features that addict and endanger Arizona children and teens.
The complaint alleges that TikTok engineered its social media platform
... Show Full Article
PHOENIX, Arizona, Oct. 9 -- Arizona Attorney General Kris Mayes issued the following news release:
* * *
Attorney General Mayes Sues TikTok for Harming Arizona Youth
October 8, 2026
PHOENIX - Attorney General Kris Mayes today announced the filing of a consumer protection lawsuit against TikTok Inc. and related entities. The complaint alleges widespread violations of the Arizona Consumer Fraud Act stemming from the company's design, marketing, and concealment of features that addict and endanger Arizona children and teens.
The complaint alleges that TikTok engineered its social media platformto maximize compulsive use among minors--including children under age 13--by deploying manipulative design tactics, including infinite scrolling, auto play, reward loops featuring harmful content, social comparison metrics, push notifications, and harmful appearance altering filters. Attorney General Kris Mayes alleges that these features were created to attract young users and keep young users engaged for as long and as often as possible so that TikTok could profit from their data.
"We allege that TikTok has repeatedly and knowingly violated the Arizona Consumer Fraud Act by designing one of the most addictive products ever targeted at children--and by concealing the severe mental, physical, and emotional health risks these design choices create," said Attorney General Mayes. "TikTok touts its supposed safety measures to convince parents that this product is safe for young people. But behind the company's marketing is a platform engineered to exploit the vulnerabilities of developing brains, pushing Arizona kids toward compulsive use, harmful content, and dangerous behaviors while failing to protect them from adults who use the social media platform to groom or solicit minors. It's unconscionable."
The lawsuit, filed today in Maricopa County Superior Court, asserts that TikTok exposes Arizona minors to a range of serious harms that the company actively minimized or failed to disclose. These include increased risks of depression, anxiety, sleep disruption, disordered eating, body image distress, and self harm. The complaint further alleges that TikTok's recommendation algorithms expose minors to increasingly extreme, harmful, or age inappropriate content and that TikTok's content moderation practices are inadequate to block much of the dangerous material on the platform.
The State also alleges that TikTok knowingly permits extensive under 13 use of its platform, despite publicly claiming to bar such users, and alleges that TikTok's design and moderation failures enable child sexual exploitation, including the circulation of child sexual abuse material through "post in private" accounts promoted by the platform's algorithm.
A review of TikTok's practices allegedly shows that the platform is intentionally constructed to appear user friendly and safe, an impression bolstered by:
* TikTok's failure to disclose the risks of addiction, compulsive use, mental health injury, sleep disruption, and other harms associated with its design elements.
* TikTok's public representations that it prioritizes teen safety and wellbeing.
* TikTok's marketing of ineffective safety tools, such as a "60 minute screen time limit," which the company allegedly knew would not reduce minors' usage.
* TikTok's withholding of safety features from some users, and use of "placebo" testing in which it misrepresents the existence of safety features to some consumers.
"Arizona's children are paying the price for TikTok's pursuit of profit. We will not tolerate a global corporation putting our kids' health, privacy, and safety at risk in order to increase advertising revenue," said Attorney General Mayes. "This lawsuit, like the landmark lawsuit against Meta, is necessary to stop TikTok's unlawful practices, hold the company accountable, and protect Arizona families from further harm."
If you believe you or your child has been a victim of consumer fraud or unfair practices, you can file a consumer complaint by visiting the Attorney General's website at www.azag.gov/consumer. If you need a complaint form sent to you, you may contact the Attorney General's Office in Phoenix at (602) 542 5763, in Tucson at (520) 628 6648, or outside the Phoenix and Tucson metro areas at (800) 352 8431.
A copy of the complaint is available here.
* * *
Original text here: https://www.azag.gov/press-release/attorney-general-mayes-sues-tiktok-harming-arizona-youth
